Share chart Cytek Biosciences, Inc.
Extended chart
Simple chart
About Cytek Biosciences, Inc.
Cytek Biosciences, Inc. занимается производством и продажей решений для клеточного анализа для клинических и биомедицинских исследований в области разработки лекарств, геномики, иммуноонкологии, иммунопрофилирования, инфекционных и воспалительных заболеваний, а также приложений для стандартизации в нескольких лабораториях. Его инструменты включают системы Aurora и Northern Lights, которые представляют собой проточные цитометры для проведения анализа клеток за счет использования флуоресцентных сигнатур от нескольких лазеров для различения флуоресцентных меток на отдельных клетках. more detailsMain settings
IPO date | 2021-07-23 |
---|---|
ISIN | US23285D1090 |
Industry | Health Care Equipment & Supplies |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | link |
Цена ао | 2.42 |
Change price per day: | 0% (2.42) |
---|---|
Change price per week: | -9.02% (2.66) |
Change price per month: | -35.81% (3.77) |
Change price per 3 month: | -52.83% (5.13) |
Change price per half year: | -62.77% (6.5) |
Change price per year: | -59.19% (5.93) |
Change price per 3 year: | -77.88% (10.94) |
Change price per year to date: | -62.71% (6.49) |
Grade
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Main owners
Institutions | Volume | Share, % |
---|---|---|
Blackrock Inc. | 17 779 753 | 13.59 |
Brown Capital Management, LLC | 12 016 325 | 9.19 |
Vanguard Group Inc | 11 890 700 | 9.09 |
RA Capital Management, L.P. | 6 809 404 | 5.21 |
HHLR Advisors, LTD | 6 657 030 | 5.09 |
State Street Corporation | 3 997 769 | 3.06 |
New York State Common Retirement Fund | 2 947 986 | 2.25 |
Geode Capital Management, LLC | 2 456 535 | 1.88 |
Wellington Management Group, LLP | 1 291 258 | 0.99 |
Northern Trust Corporation | 1 190 624 | 0.91 |
Contained in ETF
ETF | Share, % | Profitability for 1 year, % | Dividends, % |
---|---|---|---|
Syntax Stratified SmallCap ETF | 0.16603 | 13.51 | 1.639 |
0.17 | 13.51 | 1.64 |
Similar companies
P/E & P/BV
Company management
Head | Job title | Payment | Year of birth |
---|---|---|---|
Dr. Wenbin Jiang Ph.D. | President, CEO & Chairman of the Board | 964.21k | 1964 (61 year) |
Mr. Patrik Sebastian Jeanmonod | Head of Corporate Development Analytics | 412.54k | 1967 (58 years) |
Dr. Ming Yan Ph.D. | CTO & Director | 616.26k | 1963 (62 years) |
Dr. Allen B. Poirson Ph.D. | Senior Vice President of Business & Corporate Development | N/A | 1960 (65 years) |
Ms. Valerie T. Barnett J.D. | Chief Legal Officer & Corporate Secretary | 535.98k | 1975 (50 years) |
Dr. Philippe Busque Ph.D. | Senior Vice President of Global Sales & Services | N/A | 1971 (54 years) |
Mr. William D. McCombe | Chief Financial Officer | N/A | 1958 (67 years) |
About company
Address: United States, Fremont. CA, 47215 Lakeview Boulevard - Open in google maps, Open in yandex maps
Website: https://cytekbio.com
Website: https://cytekbio.com